HALO logo
halo search icon
Nurexone Biologic Inc

CA$0.64

Price Change Indicator
-0.01 (-1.538%)
Nurexone Biologic Inc
NRX · TSX

Nurexone Biologic Inc

Start Trading NRX for Free

CA$0.64

Price Arrow-0.01 (-1.538%)
20/05/2026 12:00:00 AM
All-CompaniesAll-ConsensusHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Nurexone Biologic Inc Overview

NRX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About NRX

icon

Website

Nurexone Biologic Inc

icon

Telephone

1.000.000.0000

icon

Address

Suite 801, 1 Adelaide Street East, Toronto, ON M5C 2V9

Description

NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. It focuses on the treatment of spinal cord injury, traumatic brain injury, and other brain and neurological indications. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.

NRX Price Chart

Key Stats

Market Cap

CA$47.71M

PE

7.20

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.54 - 1.14

Trade Value (12mth)

US$5,454.00

1 week

-3.03%

1 month

1.59%

YTD

-1.54%

1 year

-4.48%

All time high

1.19

Key Fundamentals

EPS 3 yr Growth

-63.10%

EBITDA Margin

0.00%

Operating Cashflow

-$5m

Free Cash Flow Return

-195.30%

ROIC

-276.40%

Interest Coverage

-198.00

Quick Ratio

2.60

Other Data

Shares Outstanding (Fully Diluted)

80m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

NRX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.08-0.08-0.08locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.08-0.08-0.08locklocklock
Growth
 %locklocklocklock62.45.2-3.5locklocklock
PE
 XlocklocklocklockN/AN/A7.2locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Nurexone Biologic Inc (NRX:TSX)?
Halo FAQ
The current share price of Nurexone Biologic Inc (NRX:TSX) is CAD$0.64.
What is the 52-week high share price for Nurexone Biologic Inc (NRX:TSX)?
Halo FAQ
The 52-week high share price for Nurexone Biologic Inc (NRX:TSX) is CAD$1.14.
What is the 52-week low share price for Nurexone Biologic Inc (NRX:TSX)?
Halo FAQ
The 52-week low share price for Nurexone Biologic Inc (NRX:TSX) is CAD$0.54.
What is the dividend yield for Nurexone Biologic Inc (NRX:TSX)?
Halo FAQ
Nurexone Biologic Inc (NRX:TSX) does not pay a dividend.
What was Nurexone Biologic Inc (NRX:TSX) last dividend payment?
Halo FAQ
Nurexone Biologic Inc (NRX:TSX) does not pay a dividend.
What is the franking level for Nurexone Biologic Inc (NRX:TSX)?
Halo FAQ
Nurexone Biologic Inc (NRX:TSX) has a franking level of 0.00%.
In which sector is Nurexone Biologic Inc (NRX:TSX) classified?
Halo FAQ
Nurexone Biologic Inc (NRX:TSX) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Nurexone Biologic Inc (NRX:TSX)?
Halo FAQ
The current P/E ratio for Nurexone Biologic Inc (NRX:TSX) is 7.20.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial